ArticleCureus2026
Posterior Reversible Encephalopathy Syndrome (PRES) Associated With Eclampsia in a Pregnant Adolescent: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We report the case of a 16-year-old pregnant woman at 35.4 weeks' gestation who was admitted with severe headache, lower extremity edema, and severe hypertension. Initial evaluation revealed significant proteinuria and elevated lactate dehydrogenase (LDH) levels, consistent with severe preeclampsia, leading to an emergency cesarean section. In the immediate postoperative period, the patient developed a generalized tonic-clonic seizure associated with refractory hypertension, requiring intravenous antihypertensive and antiseizure therapy. Brain magnetic resonance imaging (MRI) demonstrated findings consistent with posterior reversible encephalopathy syndrome (PRES). Comprehensive management was initiated, including magnesium sulfate, strict blood pressure control, and anticonvulsants, resulting in a favorable neurological outcome without residual focal deficits. This case highlights the importance of early recognition of PRES in patients with preeclampsia/eclampsia, given its potential reversibility with timely treatment.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.